Loading…
Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 This bill specifies that certain Medicare payment rules applicable to imaging services shall apply to dual-energy x-ray absorptiometry services used in bone mass scans beginning in 2022. The bill also establishes national minimum payment amounts for such services.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (11)
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S3900)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2023 · fourth_quarter · Medicare/Medicaid
Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022. H.R.2471 - Consolidated Appropriations Act, 2022. S.1943/H.R.3517 - Issues related to DXA scans, osteoporosis.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022. H.R.2471 - Consolidated Appropriations Act, 2022. S.1943/H.R.3517 - Issues related to DXA scans, osteoporosis.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022. H.R.2471 - Consolidated Appropriations Act, 2022. S.1943/H.R.3517 - Issues related to DXA scans, osteoporosis.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Medicare/Medicaid
Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022. H.R.2471 - Consolidated Appropriations Act, 2022. S.1943/H.R.3517 - Issues related to DXA scans, osteoporosis.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Public law 117-1769 Inflation Reduction Act HR 2617 Consolidated Appropriations Act of 2023 Issues related to drug pricing reform and Medicare Part D redesign S. 1943 and H.R. 3517, Issues related to DXA scans, osteoporosis issues related to cardiovascular disease awareness Issues related to ESRD Issues related to asthma and self-administered drug list Reimbursement for biologics/biosimilars Issues related to discarded drugs
Client expense: $2,140,000 · Firm income: Not reported
| Democratic |
| NV |
| Debbie Stabenow | Democratic | MI |
| Jacky Rosen | Democratic | NV |
| John Cornyn | Republican | TX |
| Jon Tester | Democratic | MT |
| Kyrsten Sinema | Independent | AZ |
| Martin Heinrich | Democratic | NM |
| Richard Blumenthal | Democratic | CT |
| Robert Menendez | Democratic | NJ |
| Roger F. Wicker | Republican | MS |
| Roger Marshall | Republican | KS |
| Shelley Moore Capito | Republican | WV |
| Sherrod Brown | Democratic | OH |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Generally for improved Medicare support for preventing secondary fractures (no specific legislation).
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Increasing awareness of bone health and osteoporosis. Generally for improved Medicare support for preventing secondary fractures (no specific legislation). Increasing public information about bone health and osteoporosis.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Monitored implementation of H.R. 5376 (P.L. 117-169), the Inflation Reduction Act and issues regarding drug pricing. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Issues regarding ESRD payments.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Public law 117-1769 Inflation Reduction Act HR 2617 Consolidated Appropriations Act of 2023 Issues related to drug pricing reform and Medicare Part D redesign S. 1943 and H.R. 3517, Issues related to DXA scans, osteoporosis issues related to cardiovascular disease awareness Issues related to ESRD Issues related to asthma and self-administered drug list Reimbursement for biologics/biosimilars Issues related to discarded drugs
Client expense: $2,140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare/Medicaid payment reform. H.R.5376 - Inflation Reduction Act of 2022. H.R.2471 - Consolidated Appropriations Act, 2022. Issues related to DXA scans, osteoporosis. S.1943/H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues related to capping out-of-pocket costs; Issues related to payments for ESRD services under Medicare; Issues related to Medicare Part D drug rebates; S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 H.R. 5376 Inflation Reduction Act - drug pricing implementation
Client expense: Not reported · Firm income: $22,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
H.R. 5376 - Build Back Better Act - drug pricing provisions S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 H.R. 5376 Inflation Reduction Act - drug pricing provisions
Client expense: Not reported · Firm income: $22,500
Government targets: SENATE
2022 · third_quarter · Medicare/Medicaid
H.R.5376 - Build Back Better Act. H.R.2471 - Consolidated Appropriations Act, 2022. DXA Reimbursement, S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Generally for improved Medicare support for preventing secondary fractures (no specific legislation).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Increasing awareness of bone health and osteoporosis. Generally for improved Medicare support for preventing secondary fractures (no specific legislation). Increasing public information about bone health and osteoporosis.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies. Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Policies related to end stage renal disease treatment. H.R. 3517 and S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act. H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
H.R. 5376 (P.L. 117-169), the Inflation Reduction Act and issues regarding drug pricing. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Issues related to the Self-Administered Drug (SAD) List. Issues regarding ESRD payments.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Issues related to drug pricing reform and Medicare Part D redesign H.R. 5376 Build Back Better Act S. 1943 and H.R. 3517, Issues related to DXA scans, osteoporosis issues related to cardiovascular disease awareness Issues related to ESRD bundle Issues related to asthma and self-administered drug list S. 2428 False Claims Amendments Act of 2021 Reimbursement for biologics/biosimilars Issues related to discarded drugs
Client expense: $3,150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Medicare/Medicaid
H.R. 5376 - Build Back Better Act, Subtitle J; Inflation Reduction Act of 2022 (PL 117-169), Subtitle B - Prescription Drug Pricing Reform; Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; Issues related to capping out-of-pocket costs; Issues related to the Self Administered Drug Exclusion List; Issues related to payments for ESRD services under Medicare; Issues related to Medicare Part D drug rebates; S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021; Issues related to proposed national coverage decision (NCD) for Medicare beneficiaries with Alzheimer's.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
H.R. 5376 - Build Back Better Act - drug pricing provisions S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: $22,500
Government targets: SENATE
2022 · second_quarter · Medicare/Medicaid
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies. Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Policies related to end stage renal disease treatment. H.R. 3517 and S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act. Build Back Better Act budget, a bill to provide budget reconciliation. H.R. 3. H.R. 19.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Issues related to drug pricing reform and Medicare Part D redesign H.R. 5376 Build Back Better Act S. 1943 and H.R. 3517, Issues related to DXA scans, osteoporosis Issues related to the 340B program issues related to cardiovascular disease awareness Issues related to ESRD bundle Issues related to asthma and self-administered drug list S. 2428 False Claims Amendments Act of 2021 Reimbursement for biologics/biosimilars Issues related to discarded drugs
Client expense: $2,070,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Medicare/Medicaid
H.R.5376 - Build Back Better Act. H.R.2471 - Consolidated Appropriations Act, 2022. DXA Reimbursement, S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
H.R. 5376, The Build Better Back Act and issues regarding drug pricing. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Issues related to the Self-Administered Drug (SAD) List.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Telemedicine coverage and reimbursement (general); Medicare reimbursement (general); Health Care Reform (general); Center for Medicare and Medicaid Innovation (CMMI); Medicaid DSH Payments (general); HHS 42 CFR Subpart B (general); Access to contraception (general) Durable Medical Equipment (general); Maternal Mortality and Morbidity (general); COVID-19 Response (general); COVID-19 vaccines (general); S.801, Connected MOM Act; H.R. 2903/S.1515, CONNECT for Health Act; H.R. 3345, Helping MOMS Act; Extending Medicaid coverage to 12 months postpartum; Medicare Sequestration (general); H.R.2256/S. 834, Resident Physician Shortage Reduction Act; Consumer Assistance Programs (CMS); H.R. 4110, Reducing Hereditary Cancer Act; Implementation of new Graduate Medical Education slots contained in P.L. 116-260, Consolidated Appropriations Act, 2021; H.R. 3173/S.3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 1025, the Kids Access to Primary Care Act of 2021; S. 1833, the Ensuring Access to Primary Care for Women & Children Act; H.R. 3517/S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021; H.R. 1978/S. 912, Protecting Seniors Through Immunization Act; H.R. 6020, Supporting Medicare Providers Act of 2021; Implementation of P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act; H.R. 5612, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule; H.R.5376/S. ___, Build Back Better Act; H.R.6612, Advancing Maternal Health Equity Under Medicaid Act; H.R. 2234/S. 1021, Equal Access to Abortion Coverage (EACH) Act;
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Increasing awareness of bone health and osteoporosis. Generally for improved Medicare support for preventing secondary fractures (no specific legislation). Increasing public information about bone health and osteoporosis.
Client expense: Not reported · Firm income: $10,000
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Generally for improved Medicare support for preventing secondary fractures (no specific legislation).
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · second_quarter · Medicare/Medicaid
H.R. 5376 - Build Back Better Act, Subtitle J; Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; Issues related to capping out-of-pocket costs; Issues related to the Self Administered Drug Exclusion List; Issues related to payments for ESRD services under Medicare; Issues related to Medicare Part D drug rebates; S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021; Issues related to proposed national coverage decision (NCD) for Medicare beneficiaries with Alzheimer's.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
H.R. 5376 - Build Back Better Act - drug pricing provisions S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: $22,500
Government targets: SENATE
2022 · first_quarter · Budget/Appropriations
S. 1943, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act H.R. 5376, Build Back Better Act (prescription drug pricing) H.R. 2471, the Consolidated Appropriations Act (340B provisions and potential drug pricing provisions) The FDA User Fee Reauthorizations (no bill numbers yet)
Client expense: Not reported · Firm income: Not reported
2022 · first_quarter · Health Issues
S. 1943, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act H.R. 5376, Build Back Better Act (prescription drug pricing) H.R. 2471, the Consolidated Appropriations Act (340B provisions and potential drug pricing provisions) The FDA User Fee Reauthorizations (no bill numbers yet)
Client expense: Not reported · Firm income: Not reported
2022 · first_quarter · Medicare/Medicaid
S. 1943, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act H.R. 5376, Build Back Better Act (prescription drug pricing) H.R. 2471, the Consolidated Appropriations Act (340B provisions and potential drug pricing provisions) The FDA User Fee Reauthorizations (no bill numbers yet)
Client expense: Not reported · Firm income: Not reported
2022 · first_quarter · Medicare/Medicaid
S. 99 The Medicare Drug Price Negotiation Act, issues related to international reference pricing and Part D redesign H.R. 3 Lower Drug Costs Now Act, issues related to international reference pricing and Part D redesign H.R. 5376 Build Back Better Act, issues related to international reference pricing and Part D redesign S. 1943 and H.R. 3517, Issues related to DXA, osteoporosis HR 2471 Consolidated Appropriations Act 2022, Issues related to the 340B program HR 2471, Consolidated appropriations Act of 2022, ESRD bundle, calcimimetic access H.R. 19 Lower Costs, More Cures Act of 2021, issues related to international reference pricing and Part D redesign H.R. 5260 Reduced Costs and Continued Cures Act, issues related to international reference pricing and Part D redesign Issues related to prescription drug pricing and Part D redesign S. 2428 False Claims Amendments Act of 2021 Reimbursement for biologics/biosimilars
Client expense: $2,780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Medicare/Medicaid
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies. Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Policies related to end stage renal disease treatment. H.R. 3517 and S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act. Build Back Better Act budget, a bill to provide budget reconciliation. H.R. 3. H.R. 19.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Telemedicine coverage and reimbursement (general); Medicare reimbursement (general); Health Care Reform (general); Center for Medicare and Medicaid Innovation (CMMI); Medicaid DSH Payments (general); HHS 42 CFR Subpart B (general); Access to contraception (general) Durable Medical Equipment (general); Maternal Mortality and Morbidity (general); COVID-19 Response (general); COVID-19 vaccines (general); S.801, Connected MOM Act; H.R. 2903/S.1515, CONNECT for Health Act; H.R. 3345, Helping MOMS Act; Extending Medicaid coverage to 12 months postpartum; Medicare Sequestration (general); H.R.2256/S. 834, Resident Physician Shortage Reduction Act; Consumer Assistance Programs (CMS); H.R. 4110, Reducing Hereditary Cancer Act; Implementation of new Graduate Medical Education slots contained in P.L. 116-260, Consolidated Appropriations Act, 2021; H.R. 3173/S.3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 1025, the Kids Access to Primary Care Act of 2021; S. 1833, the Ensuring Access to Primary Care for Women & Children Act; H.R. 3517/S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021; H.R. 1978/S. 912, Protecting Seniors Through Immunization Act; H.R. 6020, Supporting Medicare Providers Act of 2021; Implementation of P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act; H.R. 5612, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule; H.R.5376/S. ___, Build Back Better Act; H.R.6612, Advancing Maternal Health Equity Under Medicaid Act.
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Generally for improved Medicare support for preventing secondary fractures (no specific legislation).
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · first_quarter · Health Issues
S.1943, "Increasing Access to Osteoporosis Screening for Medicare Beneficiaries Act of 2021." Increasing awareness of bone health and osteoporosis. Generally for improved Medicare support for preventing secondary fractures (no specific legislation).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; Issues related to payments for ESRD services under Medicare; Issues related to Medicare Part D drug rebates; S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021; Issues related to proposed national coverage decision (NCD) for Medicare beneficiaries with Alzheimers.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
H.R. 5376, The Build Better Back Act and issues regarding drug pricing. Issues regarding ESRD payments. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medicare/Medicaid
S. 99 The Medicare Drug Price Negotiation Act, issues related to international reference pricing and Part D redesign H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act, issues related to international reference pricing and Part D redesign S. 1943 and H.R. 3517, Issues related to DXA, osteoporosis Issues related to international reference pricing Issues related to the 340B program, no specific bill Reimbursement for biologics/biosimilars Issues related to Medicare Part D redesign Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters ESRD bundle, calcimimetic access, no specific bill H.R. 19 Lower Costs, More Cures Act of 2021, issues related to international reference pricing and Part D redesign H.R. 5260 Reduced Costs and Continued Cures Act, issues related to international reference pricing and Part D redesign S. 2428 False Claims Amendments Act of 2021 H.R. 5376 Build Back Better Act, issues related to international reference pricing and Part D redesign H.R. 5801 HELP Copays Act
Client expense: $2,410,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Medicare/Medicaid
H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021, S.1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medicare/Medicaid
S. 99 The Medicare Drug Price Negotiation Act, issues related to international reference pricing and Part D redesign H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act, issues related to international reference pricing and Part D redesign S. 1943 and H.R. 3517, Issues related to DXA, osteoporosis Issues related to international reference pricing Issues related to the 340B program, no specific bill Reimbursement for biologics/biosimilars Issues related to Medicare Part D redesign Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters ESRD bundle, calcimimetic access, no specific bill H.R. 19 Lower Costs, More Cures Act of 2021, issues related to international reference pricing and Part D redesign H.R. 5260 Reduced Costs and Continued Cures Act, issues related to international reference pricing and Part D redesign S. 2428 False Claims Amendments Act of 2021 H.R. 5376 Build Back Better Act, issues related to international reference pricing and Part D redesign H.R. 5801 HELP Copays Act
Client expense: $2,410,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Medicare/Medicaid
General education about policies impacting pharmaceutical development, approval, reimbursement, Medicare Part D and Medicare Part B, and 340B policies. Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Policies related to end stage renal disease treatment. H.R. 3517 and S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act. Build Back Better Act budget, a bill to provide budget reconciliation. H.R. 3. H.R. 19.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medicare/Medicaid
Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Telemedicine coverage and reimbursement (general); Medicare reimbursement (general); Health Care Reform (general); Center for Medicare and Medicaid Innovation (CMMI); Medicaid DSH Payments (general); HHS 42 CFR Subpart B (general); Access to contraception (general) Durable Medical Equipment (general); Maternal Mortality and Morbidity (general); COVID-19 Response (general); COVID-19 vaccines (general); S.801, Connected MOM Act; H.R. 2903/S.1515, CONNECT for Health Act; H.R. 3345, Helping MOMS Act; Extending Medicaid coverage to 12 months postpartum; Medicare Sequestration (general); H.R.2256/S. 834, Resident Physician Shortage Reduction Act; Consumer Assistance Programs (CMS); H.R. 4110, Reducing Hereditary Cancer Act; Implementation of new Graduate Medical Education slots contained in P.L. 116-260, Consolidated Appropriations Act, 2021; H.R. 3173/S.3018, Improving Seniors Timely Access to Care Act of 2021; H.R. 1025, the Kids Access to Primary Care Act of 2021; S. 1833, the Ensuring Access to Primary Care for Women & Children Act; H.R. 3517/S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021; H.R. 1978/S. 912, Protecting Seniors Through Immunization Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S.610, Protecting Medicare and American Farmers from Sequester Cuts Act; H.R. 5612, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule; H.R.5376/S. ___, Build Back Better Act.
Client expense: $141,181 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Executive Office of the President (EOP), Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office